John Vierling

John Vierling

Directeur/Bestuurslid bij ATHENEXPAR
80 jaar
Consumer Services
Health Technology
Commercial Services

Profiel

John Moore Vierling is an Independent Director at Athenex, Inc., Chief Hepatology & Director-Baylor Liver Health at Baylor College of Medicine, Director at National Institute of Diabetes & Digestive & Kidney Diseases, and Member at National Institutes of Health.
He was formerly Chairman at Arbios Systems, Inc., Chairman at Fractyl Health, Inc., Medical Director-Multi Organ Transplantation at Cedars-Sinai Medical Center, Medical Director-Liver Transplantation at the University of Colorado Health Sciences Center, President at American Association for The Study of Liver Diseases, and Secretary & Treasurer at Digestive Disease Week.
He was also Chairman of the American Liver Foundation from 1994 to 2000.
Dr. Vierling received his undergraduate degree from Stanford University and his doctorate from Stanford University School of Medicine.

Actieve functies van John Vierling

BedrijvenFunctieBegin
ATHENEXPAR Directeur/Bestuurslid 01-04-2019
Corporate Officer/Principal 01-04-2005
Corporate Officer/Principal -
Directeur/Bestuurslid -

Eerdere bekende functies van John Vierling

BedrijvenFunctieEinde
Bedrijfssecretaris 01-07-2013
President 01-12-2007
Voorzitter 01-01-2000
FRACTYL HEALTH, INC. Corporate Officer/Principal -
Corporate Officer/Principal -
Ervaring van John Vierling in detail bekijken

Opleiding van John Vierling

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

90

Eerstegraads connecties

13

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit13

Health Technology

Health Technology

Consumer Services

Health Services

Consumer Services

Government

Consumer Services

Government

Commercial Services

Commercial Services

Commercial Services

Health Technology

Consumer Services

  1. Beurs
  2. Insiders
  3. John Vierling
DE LAATSTE UREN | -40 %: De beste tools voorbehouden aan abonnees om de beste beleggingen van morgen te identificeren!
d
:
:
PROFITEER NU